IntrinsicIntrinsic
← Scroll for more →

Financial Statements — IXHL

Balance Sheet

(in millions USD)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q4 2023Q2 2023Q4 2022
Cash & Equivalents67.7174.4568.9073.2815.046.712.103.635.869.3114.5533.3641.4237.50
Total Current Assets72.8380.1074.6878.3019.9615.6310.5015.2116.2016.3221.3334.6942.1337.88
Property, Plant & Equipment0.000.050.110.170.230.280.270.430.470.520.56------
Total Non-current Assets*0.150.190.330.430.490.570.600.840.850.931.0353.9053.09--
Total Assets72.9880.2875.0178.7220.4516.2011.1116.0517.0517.2522.36------
Accounts Payable----------------5.462.703.02------
Short-term Debt----------1.401.38--------------
Total Current Liabilities1.491.931.551.656.987.375.849.235.622.863.193.851.122.01
Long-term Debt------------2.38--------------
Total Non-current Liabilities*4.113.120.050.060.071.434.300.220.210.250.300.620.18--
Total Liabilities5.615.051.601.717.068.7910.149.455.833.113.49------
Retained Earnings(176.86)(174.37)(170.48)(163.96)(157.56)(125.95)(121.98)(116.09)(110.67)(104.21)(98.18)(78.77)--(58.79)
Total Stockholder Equity67.3775.2373.4177.0113.397.400.976.6011.2214.1418.8784.1393.9235.87
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q2 2023
Total Revenue--0.000.010.070.000.000.010.07------(0.17)
Research & Development1.490.322.281.123.702.741.412.904.363.282.64--
Selling, General & Admin3.703.734.725.673.832.273.603.435.404.145.35--
Total Operating Expenses5.194.057.006.797.535.005.026.339.767.427.98--
Operating Income(5.19)(4.05)(6.99)(6.79)(7.53)(5.00)(5.00)(6.25)(9.74)(7.41)(7.98)--
Interest Expense----------------------0.01
Pretax Income(2.49)(3.88)(6.52)(6.41)(31.60)(3.97)(5.89)(5.42)(6.43)(6.03)(5.24)(8.53)
Net Income(2.49)(3.88)(6.52)(6.41)(31.60)(3.97)(5.89)(5.42)(6.46)(6.03)(5.24)(8.53)
Basic EPS--(0.35)(0.02)(0.02)(0.53)(0.20)(0.33)(0.29)(0.39)(0.38)(0.33)(0.61)
Diluted EPS--(0.35)(0.02)(0.02)(0.53)(0.20)(0.33)(0.29)(0.39)(0.38)(0.33)(0.61)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q2 2023
Operating Cash Flow3.37(2.46)(4.62)(9.16)(1.48)(3.16)(5.68)(2.19)(3.64)(4.35)(7.85)(8.12)
Capital Expenditures-0.000.010.000.000.000.000.010.220.00(0.01)0.28--
Free Cash Flow*3.38(2.46)(4.63)(9.16)(1.48)(3.16)(5.69)(2.41)(3.64)(4.34)(8.13)--
Investing Cash Flow(0.03)(0.02)-0.00(0.04)0.000.00(0.01)(0.22)-0.000.01(0.28)(0.17)
Financing Cash Flow(6.91)4.710.9367.189.607.744.10(0.05)(0.03)(0.07)8.2812.20
← Scroll for more columns →

* Derived from reported values

Dividends Per Share

(USD)
MetricQ3 2026
Dividends Per Share49.50
← Scroll for more columns →